Clinical Case Discussion of invasive fungal infection in ICU
-
Location
Le Merdian
-
Phone
+966 112790305
- Website: www.credit-hours.com Join Event
- Email Address: info@credit-hours.com
- Email Activity Coordinator: cpd2@credit-hours.com
- Phone Activity Coordinator: +966 598987505
Event Audience
- Infection Control
- Infectious Disease
- Hematology
- Medical Oncology
- Family Medicine
- General surgery
- Pediatrics
- Internal Medicine
- Emergency Medicine
- General Practice
- Critical Care Medicine
- Dermatology
- Medical Microbiology
- Allergy and Immumology
- Pulmonology
- Public Health
- Geriatric Medicine
- Hematological Pathology
- Pediatric Surgery
- Pediatric Emergency Medicine Trauma
- Preventive Medicine
- Family and Community Medicine
- Midwifery
- Nursing
- Adult Critical Care Nursing
- Medical and Surgical Nursing
- Nursing Administration
- Primary Health Care Nursing
- Nursing Education
- Pain Management Nursing
- Oncology and Palliative Care Nursing
- Geriatric Nursing
- Pediatric Nursing Critical Care
- Emergency Care Nursing
- Wound Care Nursing
- Community and Public Health Nursing
- Disaster and Emergency Nursing
- Pre, Intra and Postoperative nursing care
- Home Health Care
- Pharmaceutical Sciences
- Clinical Pharmacy
- Pharmaceutical administration AND outcomes
- Pharmacy
- Respiratory Therapy
Event Goals
- • Describe the Identification of High-Risk Patients for Invasive Fungal Infections (IFIs) and Those Needing Preemptive or Prophylactic Therapy
- • Discuss Recent Updates in Guidelines for Managing Invasive Candidiasis and Aspergillosis in ICU Patients During the COVID-19 Era.
- • Explain the Clinical Presentation, Diagnosis, and Treatment of Candidiasis, Aspergillosis, Dematiaceous Fungal Infections, and Mucormycosis.
- • Evaluate Various Antifungal Treatment Strategies for Invasive Fungal Infections (IFIs) Based on Diagnostic Stage
- • Clarify how to select antifungal therapy based on clinical presentation and susceptibility testing
- • Choose an Empiric Antifungal Therapy Regimen for ICU Patients and how to select an empiric antifungal treatment regimen for critically ill ICU patients
- • Illustrate how to evaluate high-risk inpatients with signs or symptoms that are suggestive of systemic fungal infection.
- • Discuss the latest updated guidelines and recommendations about how to use newer antifungal agents and their relative advantages and disadvantages in the ICU setting.
Event Agenda
24/04/2025
Welcome and Introduction
19:30:00 - 19:40:00
Speaker(s):
No speakers assigned
24/04/2025
Pre-test to assess the current knowledge
19:45:00 - 19:55:00
Speaker(s):
احمد سعيد الاحمدي (AHMED SAEED ALAHMADI)
24/04/2025
Burden & Challenges of Invasive fungal Infections in ICU
20:00:00 - 20:30:00
Speaker(s):
ايمن محمد خرابه (AYMAN MOHAMMED KHARABA)
24/04/2025
Clinical Cases in IFI Workshop
20:40:00 - 21:10:00
Speaker(s):
احمد سعيد الاحمدي (AHMED SAEED ALAHMADI)
, ايمن محمد خرابه (AYMAN MOHAMMED KHARABA)
, جمانه نذير القزق (JUMANAH NAZEER ALGAZAQ)
24/04/2025
Clinical Cases Presentation & Discussion
21:20:00 - 21:50:00
Speaker(s):
احمد سعيد الاحمدي (AHMED SAEED ALAHMADI)
, ايمن محمد خرابه (AYMAN MOHAMMED KHARABA)
, جمانه نذير القزق (JUMANAH NAZEER ALGAZAQ)
24/04/2025
IFIs Management in ICU
22:00:00 - 22:30:00
Speaker(s):
جمانه نذير القزق (JUMANAH NAZEER ALGAZAQ)
24/04/2025
Case-based Discussion and Q/A session
22:40:00 - 23:10:00
Speaker(s):
احمد سعيد الاحمدي (AHMED SAEED ALAHMADI)
, ايمن محمد خرابه (AYMAN MOHAMMED KHARABA)
, جمانه نذير القزق (JUMANAH NAZEER ALGAZAQ)
24/04/2025
Post-Test
23:15:00 - 23:25:00
Speaker(s):
احمد سعيد الاحمدي (AHMED SAEED ALAHMADI)
24/04/2025
Take home messages and Closure
23:40:00 - 23:50:00
Speaker(s):
No speakers assigned
© 2024 Marvel Developed by Marvel Development Team